One Wealth Capital Management LLC Takes $255,000 Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

One Wealth Capital Management LLC bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, Holdings Channel reports. The fund bought 488 shares of the medical equipment provider’s stock, valued at approximately $255,000.

A number of other hedge funds also recently bought and sold shares of the business. Private Advisor Group LLC raised its holdings in shares of Intuitive Surgical by 18.1% during the second quarter. Private Advisor Group LLC now owns 14,019 shares of the medical equipment provider’s stock valued at $6,236,000 after acquiring an additional 2,146 shares in the last quarter. Norden Group LLC lifted its position in shares of Intuitive Surgical by 29.6% in the 2nd quarter. Norden Group LLC now owns 1,240 shares of the medical equipment provider’s stock worth $552,000 after purchasing an additional 283 shares during the period. Strategic Financial Concepts LLC boosted its stake in shares of Intuitive Surgical by 40,221.4% during the 2nd quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after purchasing an additional 265,461 shares in the last quarter. Asset Dedication LLC increased its position in shares of Intuitive Surgical by 320.0% during the second quarter. Asset Dedication LLC now owns 231 shares of the medical equipment provider’s stock valued at $103,000 after buying an additional 176 shares during the period. Finally, Acadian Asset Management LLC raised its stake in Intuitive Surgical by 19.9% in the second quarter. Acadian Asset Management LLC now owns 24,197 shares of the medical equipment provider’s stock worth $10,760,000 after buying an additional 4,009 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded down $10.48 during midday trading on Tuesday, reaching $531.89. 872,890 shares of the company’s stock traded hands, compared to its average volume of 1,039,483. Intuitive Surgical, Inc. has a one year low of $324.12 and a one year high of $556.23. The company has a market cap of $189.45 billion, a price-to-earnings ratio of 85.51, a P/E/G ratio of 5.31 and a beta of 1.39. The stock has a 50 day moving average of $533.39 and a 200 day moving average of $492.20.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 over the last quarter. Company insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the company. Wells Fargo & Company upped their target price on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.